{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:39:49Z","timestamp":1762079989972,"version":"build-2065373602"},"reference-count":14,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2003,9,19]],"date-time":"2003-09-19T00:00:00Z","timestamp":1063929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2003,10]]},"abstract":"<jats:p>Background.\u2014Intractable migraine presents a significant treatment challenge to both patient and physician. Most attacks are treatable or self\u2010limiting, but occasionally they may continue for extended periods regardless of treatment.<\/jats:p>\n                  <jats:p>Objective.\u2014To determine the efficacy of naratriptan 2.5 mg twice daily for the treatment of intractable migraine.<\/jats:p>\n                  <jats:p>Methods.\u2014We reviewed 24 patients treated with naratriptan twice daily for an intractable migraine attack. Patients were permitted to take prophylactic medication if such treatment had been effective in the past.<\/jats:p>\n                  <jats:p>Results.\u2014Nineteen patients (79%) improved. Twelve patients showed excellent response with cessation of pain and associated symptoms, 7 patients partially responded with lessening of pain and cessation of associated symptoms, and 5 patients were nonresponsive.<\/jats:p>\n                  <jats:p>Conclusion.\u2014Short\u2010term daily administration of naratriptan may be effective in terminating status migrainosus.<\/jats:p>","DOI":"10.1046\/j.1526-4610.2003.03191.x","type":"journal-article","created":{"date-parts":[[2003,9,19]],"date-time":"2003-09-19T12:23:43Z","timestamp":1063974223000},"page":"991-993","source":"Crossref","is-referenced-by-count":5,"title":["Managing Intractable Migraine With Naratriptan"],"prefix":"10.1111","volume":"43","author":[{"given":"R. Michael","family":"Gallagher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loretta","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,9,19]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"GilliesJD LanceJW.Pathophysiology of migraine. In:TollisonCD KunkelRS eds.Headache diagnosis and treatment. Baltimore :Williams & Wilkins;1993:77\u201084."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1990.hed30s2550.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1986.hed2602074.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1996.3603154.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.00032.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.4.e62"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1997.3706377.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.00133.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1997.1703145.x"},{"key":"e_1_2_6_11_2","first-page":"408","article-title":"Oral naratriptan tablet (2.5\u201310 mg) exhibit dose proportional pharmacokinetics [abstract]","volume":"17","author":"Kempsford RD","year":"1997","journal-title":"Cephalalgia"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2002.02014.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1999.3907506.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.111006248.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2001.01156.x"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1526-4610.2003.03191.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-4610.2003.03191.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1526-4610.2003.03191.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-4610.2003.03191.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:34:35Z","timestamp":1762079675000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1046\/j.1526-4610.2003.03191.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,19]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["10.1046\/j.1526-4610.2003.03191.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03191.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"type":"print","value":"0017-8748"},{"type":"electronic","value":"1526-4610"}],"subject":[],"published":{"date-parts":[[2003,9,19]]}}}